Joan W. Bennett
Distinguished Professor
Rutgers University
Christina Berberich
PHARMD,MPH, RD
Medical Science Liaison, Abbott Nutrition Research,
Scientific & Medical Affairs
Todd A. Black, Ph.D.
Executive Director
Infectious Diseases
Merck Research Laboratories
Keith Bostian, Ph.D.
CEO
Institute for Life Science Entrepreneurship
Raina Fichorova, Ph.D., MD, M.Sci (Hon)
Professor of Obstetrics, Gynecology, & Reproductive Biology
Harvard Medical School
Director of Genital Tract Biology
Brigham & Women's Hospital
Romina Goldszmid, Ph.D.
Cancer & Inflammation Program
NIH Stadtman Investigator
Harvey Homan, Ph.D.
Executive Director of Corporate Development
Institute for Life Science Entrepreneurship
Gerard Honig, Ph.D.
Founder & CEO
Symbiotic Health
Sathapana (Sam) Kongsamut, Ph.D.*
Owner and Principal
Rudder Serendip LLC
Winston Kuo, DMSc
President
Predicine Holdings, Ltd
Laurel Lagenaur, Ph.D.
Senior Scientist
OSEL
Sridhar Mani, MD
Professor of Medicine
Albert Einstein School of Medicine
Camilia R. Martin, M.D., M.S.
Assistant Professor of Pediatrics
Harvard Medical School
The Establishment of the Early Microbiome in Neonates:
Determinants, Risks, & Therapeutics
John Pace, Ph.D.
Executive Director, Scientific Research
ATCC Center for Translational Microbiology
Institute for Life Science Entrepreneurship
Sean University
Tasha Santiago-Rodriguez, Ph.D.
Scientist
ATCC-Center for Translational Microbiology
Institute for Life Science Entrepreneurship
Howard Young, Ph.D.
Senior Investigator
Cancer &
Inflammation Program
Center for Cancer Research
NCI at Frederick
Frederick, MD
With the explosion in microbiome research, emerging studies suggest a growing appreciation of this complex environment's roles. Join your colleagues from academic and industry labs to share deepening understanding of the impact on disease/health states, immunology, and the importance of very early exposure to the mother.
This Symposium will Address:
-Overview of Collaborations, progress in understanding the Microbiome
-Current Research on the flow of the Microbiome from mother to child
-The interplay of the Microbiome with Immunotherapy
-Methods and Validation Technologies for Microbiome Research
-Industry Perspectives- Leveraging Knowledge of the Microbiome
This program is a follow-up to "Altering the Microbiome: Can it Impact Health?" co-organized by the BioPharma Research Council and the National Cancer Institute last year. Click here for the 2015 agenda.
*Committee Member
